دورية أكاديمية

Forward and reverse typing discrepancy and crossmatch incompatibility of ABO blood groups: cause analysis and treatment.

التفاصيل البيبلوغرافية
العنوان: Forward and reverse typing discrepancy and crossmatch incompatibility of ABO blood groups: cause analysis and treatment.
المؤلفون: Qiu H; Department of Blood Transfusion, The First Hospital of Jiaxing, Jiaxing, People's Republic of China., Wang X; Department of Blood Transfusion, The First Hospital of Jiaxing, Jiaxing, People's Republic of China., Shao Y; Department of Laboratory, The Second People's Hospital of Pinghu, Pinghu, People's Republic of China.
المصدر: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2240146.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE
أسماء مطبوعة: Publication: 2016- : Abingdon : Taylor & Francis
Original Publication: [Amsterdam] : Newark, NJ : Harwood Academic Publishers ; International Publishers Distributor,
مواضيع طبية MeSH: Blood Grouping and Crossmatching* , ABO Blood-Group System*, Humans ; Blood Transfusion/methods ; Bone Marrow Transplantation
مستخلص: Objective: Analyze the reasons for the mismatch between forward and reverse typing of ABO blood types and the mismatch between cross matching.
Methods: When the forward and reverse typing do not match, use physiological saline method, polyamine method, anti human globulin method, and anti screening positive samples are used for antibody identification.
Results: The factors contributing to discrepancies in blood typing between forward and reverse typing include weakened serum typing, condensation, monoclonal immunoglobulin influence, bone marrow transplantation, and blood type subtypes. The causes of cross matching incompatibility include homologous antibody, warm Autoantibody, cold Autoantibody and daretozumab.
Conclusion: Regular red blood cell homologous antibody screening should be conducted based on disease type, blood transfusion history, and medication history. Antigen matched red blood cells should be selected for cross matching, and different experimental methods should be used for testing to ensure the safety of clinical blood transfusion.
فهرسة مساهمة: Keywords: Crossmatch incompatibility; discrepant forward and reverse blood group typing of ABO blood groups; interfering factors
المشرفين على المادة: 0 (ABO Blood-Group System)
تواريخ الأحداث: Date Created: 20230803 Date Completed: 20230804 Latest Revision: 20230804
رمز التحديث: 20231215
DOI: 10.1080/16078454.2023.2240146
PMID: 37535059
قاعدة البيانات: MEDLINE
الوصف
تدمد:1607-8454
DOI:10.1080/16078454.2023.2240146